Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial

Prostate cancer screening remains controversial because potential mortality or quality-of-life benefits may be outweighed by harms from overdetection and overtreatment. To evaluate the effect of a single prostate-specific antigen (PSA) screening intervention and standardized diagnostic pathway on pr...

Celý popis

Podrobná bibliografie

Vydáno v:	JAMA : the journal of the American Medical Association Ročník 319; číslo 9; s. 883
Hlavní autoři:	Martin, Richard M, Donovan, Jenny L, Turner, Emma L, Metcalfe, Chris, Young, Grace J, Walsh, Eleanor I, Lane, J Athene, Noble, Sian, Oliver, Steven E, Evans, Simon, Sterne, Jonathan A C, Holding, Peter, Ben-Shlomo, Yoav, Brindle, Peter, Williams, Naomi J, Hill, Elizabeth M, Ng, Siaw Yein, Toole, Jessica, Tazewell, Marta K, Hughes, Laura J, Davies, Charlotte F, Thorn, Joanna C, Down, Elizabeth, Davey Smith, George, Neal, David E, Hamdy, Freddie C
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 06.03.2018
Témata:	Age Distribution Aged Early Detection of Cancer Follow-Up Studies Humans Male Mass Screening Middle Aged Primary Health Care Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - diagnosis Prostatic Neoplasms - mortality Social Class United Kingdom - epidemiology
ISSN:	1538-3598, 1538-3598
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!